COMPANIES | Cancer Alliance to participate in excessive pricing case against Roche
The Competition Tribunal has approved the Cancer Alliance's interest in participating in the legal submissions by the Competition Commission against the multinational healthcare company, Roche regarding overpricing the trastuzumab breast cancer medicine.